| Association of reactive oxygen species levels and radioresistance in cancer stem cells M Diehn, RW Cho, NA Lobo, T Kalisky, MJ Dorie, AN Kulp, D Qian, ... nature 458 (7239), 780-783, 2009 | 2829 | 2009 |
| Trastuzumab emtansine for residual invasive HER2-positive breast cancer G Von Minckwitz, CS Huang, MS Mano, S Loibl, EP Mamounas, M Untch, ... New England Journal of Medicine 380 (7), 617-628, 2019 | 2113 | 2019 |
| Long-term outcomes of invasive ipsilateral breast tumor recurrences after lumpectomy in NSABP B-17 and B-24 randomized clinical trials for DCIS IL Wapnir, JJ Dignam, B Fisher, EP Mamounas, SJ Anderson, TB Julian, ... Journal of the National Cancer Institute 103 (6), 478-488, 2011 | 861 | 2011 |
| Society of Surgical Oncology–American Society for Radiation Oncology–American Society of Clinical Oncology consensus guideline on margins for breast-conserving surgery with … M Morrow, KJ Van Zee, LJ Solin, N Houssami, M Chavez-MacGregor, ... Annals of surgical oncology 23, 3801-3810, 2016 | 648 | 2016 |
| The mammary gland iodide transporter is expressed during lactation and in breast cancer UH Tazebay, IL Wapnir, O Levy, O Dohan, LS Zuckier, Q Hua Zhao, ... Nature medicine 6 (8), 871-878, 2000 | 635 | 2000 |
| Prognosis after ipsilateral breast tumor recurrence and locoregional recurrences in five National Surgical Adjuvant Breast and Bowel Project node-positive adjuvant breast … IL Wapnir, SJ Anderson, EP Mamounas, CE Geyer Jr, JH Jeong, ... Journal of Clinical Oncology 24 (13), 2028-2037, 2006 | 537 | 2006 |
| In situ vaccination with a TLR9 agonist induces systemic lymphoma regression: a phase I/II study JD Brody, WZ Ai, DK Czerwinski, JA Torchia, M Levy, RH Advani, YH Kim, ... Journal of clinical oncology 28 (28), 4324, 2010 | 518 | 2010 |
| Prognosis after ipsilateral breast tumor recurrence and locoregional recurrences in patients treated by breast-conserving therapy in five National Surgical Adjuvant Breast and … SJ Anderson, I Wapnir, JJ Dignam, B Fisher, EP Mamounas, JH Jeong, ... Journal of Clinical Oncology 27 (15), 2466, 2009 | 506 | 2009 |
| Immunohistochemical profile of the sodium/iodide symporter in thyroid, breast, and other carcinomas using high density tissue microarrays and conventional sections IL Wapnir, M van de Rijn, K Nowels, PS Amenta, K Walton, K Montgomery, ... The Journal of Clinical Endocrinology & Metabolism 88 (4), 1880-1888, 2003 | 368 | 2003 |
| New models and online calculator for predicting non-sentinel lymph node status in sentinel lymph node positive breast cancer patients HE Kohrt, RA Olshen, HR Bermas, WH Goodson, DJ Wood, S Henry, ... BMC cancer 8, 1-15, 2008 | 344 | 2008 |
| Phase II study of gemcitabine, carboplatin, and iniparib as neoadjuvant therapy for triple-negative and BRCA1/2 mutation–associated breast cancer with assessment of a tumor … ML Telli, KC Jensen, S Vinayak, AW Kurian, JA Lipson, PJ Flaherty, ... Journal of Clinical Oncology 33 (17), 1895, 2015 | 260 | 2015 |
| Chemotherapy for isolated locoregional recurrence of breast cancer (CALOR): a randomised trial S Aebi, S Gelber, SJ Anderson, I Láng, A Robidoux, M Martín, ... The lancet oncology 15 (2), 156-163, 2014 | 215 | 2014 |
| Oncologic procedures amenable to fluorescence-guided surgery KE Tipirneni, JM Warram, LS Moore, AC Prince, E de Boer, AH Jani, ... Annals of surgery 266 (1), 36-47, 2017 | 152 | 2017 |
| The Na+/I− symporter mediates iodide uptake in breast cancer metastases and can be selectively down-regulated in the thyroid IL Wapnir, M Goris, A Yudd, O Dohan, D Adelman, K Nowels, N Carrasco Clinical Cancer Research 10 (13), 4294-4302, 2004 | 152 | 2004 |
| Initial results with preoperative tattooing of biopsied axillary lymph nodes and correlation to sentinel lymph nodes in breast cancer patients N Choy, J Lipson, C Porter, M Ozawa, A Kieryn, S Pal, J Kao, L Trinh, ... Annals of surgical oncology 22, 377-382, 2015 | 122 | 2015 |
| Efficacy of chemotherapy for ER-negative and ER-positive isolated locoregional recurrence of breast cancer: final analysis of the CALOR trial IL Wapnir, KN Price, SJ Anderson, A Robidoux, M Martín, JWR Nortier, ... Journal of clinical oncology 36 (11), 1073, 2018 | 120 | 2018 |
| KATHERINE investigators. Trastuzumab emtansine for residual invasive HER2-positive breast cancer G Von Minckwitz, CS Huang, MS Mano, S Loibl, EP Mamounas, M Untch, ... N Engl J Med 380 (7), 617-628, 2019 | 102 | 2019 |
| Maastricht Delphi consensus on event definitions for classification of recurrence in breast cancer research M Moossdorff, LM Van Roozendaal, LJA Strobbe, S Aebi, DA Cameron, ... Journal of the National Cancer Institute 106 (12), dju288, 2014 | 97 | 2014 |
| Outcomes of partial mastectomy in male breast cancer patients: analysis of SEER, 1983–2009 JM Cloyd, T Hernandez-Boussard, IL Wapnir Annals of surgical oncology 20, 1545-1550, 2013 | 92 | 2013 |
| Patient-derived xenografts of triple-negative breast cancer reproduce molecular features of patient tumors and respond to mTOR inhibition H Zhang, AL Cohen, S Krishnakumar, IL Wapnir, S Veeriah, G Deng, ... Breast Cancer Research 16, 1-16, 2014 | 88 | 2014 |
Nancy CarrascoVanderbilt UniversityVerified email at vanderbilt.edu
